QDF-26756-18634 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2023-01-06
Dose 1 — Pfizer-BioNTech
Co-administered: Chickenpox:Flu:MMR
2023-01-11
Registered in v-safe
2023-01-11
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Irritability/crying, Vomiting

Under 3 check-in
2023-01-12
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2023-01-14
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2023-01-20
Survey response — day 14, dose 1, under 3
MedDRA: Pyrexia, Urticaria, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

MedDRA releases: 2024-11
2023-01-20
Report sent to call center — day 14, dose 1, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2023-01-23
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2023-01-06	Pfizer-BioNTech	Chickenpox:Flu:MMR

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Pyrexia	·	·	✓
SD	Urticaria	·	·	✓
SD	Vomiting	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release